Industry experts dismiss feasibility of splitting MMR vaccine as ordered by Trump
Although splitting the measles, mumps, and rubella vaccine into separate shots is theoretically possible, vaccine manufacturers and clinical development veterans say it is impractical. The recent presidential order to separate the MMR vaccine faces significant logistical and regulatory hurdles. Companies are pushing back against the feasibility of such a move.
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Vaccine makers throw cold water on separating MMR vaccine.” Browse more stories.